Leunen, Karin <br/><br/>
Does paclitaxel-carboplatin chemotherapy in a dose-dense regimen enhance survival of BRCA-related ovarian cancer patients?  [electronic resource] 

 -  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society  Dec 2009 
 - 1501-4 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1525-1438 
<br/><br/><label>Standard No.: </label>10.1111/IGC.0b013e3181bb703f  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>BRCA1 Protein--genetics<br/>Carboplatin--administration & dosage<br/>Carcinoma--drug therapy<br/>Cell Transformation, Neoplastic--genetics<br/>Dose-Response Relationship, Drug<br/>Female<br/>Genetic Predisposition to Disease<br/>Humans<br/>Middle Aged<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome